CG
BMY icon

Cynosure Group’s Bristol-Myers Squibb BMY Stock Holding History

Cynosure Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,475
Closed -$565K – 236
2025
Q4 		$565K Buy
+10,475
New +$504K 0.06% 122
2023
Q3 		– Sell
-4,750
Closed -$304K – 142
2023
Q2 		$304K Buy
+4,750
New +$319K 0.09% 115
2020
Q2 		– Sell
-6,604
Closed -$368K – 23
2020
Q1 		$368K Sell
6,604
-1,164
-15% -$71.1K 0.26% 43
2019
Q4 		$499K Buy
7,768
+953
+14% +$54.6K 0.27% 36
2019
Q3 		$346K Sell
6,815
-2,410
-26% -$113K 0.19% 55
2019
Q2 		$418K Buy
+9,225
New +$430K 0.19% 59

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cynosure Group's BMY Position: Q1 2026 in Review

Cynosure Group sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 10,475 shares — an estimated $565K sold.

Cynosure Group first reported a position in BMY in Q2 2019 and held it in 6 quarters. The position peaked at $565K in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Cynosure Group reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 10,475 Bristol-Myers Squibb shares in Q1 2026, an estimated $565K.
  • Cynosure Group first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 6 quarters.
  • Cynosure Group's Bristol-Myers Squibb position peaked at $565K in Q4 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.